AIM: To objectively measure levels of physical activity in children, following treatment for acute lymphoblastic leukaemia (ALL). METHODS: Nineteen children who had completed treatment for ALL 6 months-5 years prior to study enrollment wore an accelerometer for 2 weekdays and 2 weekend days. RESULTS: The children spent an average of 141 +/- 74 min/day engaged in moderate to vigorous physical activity (MVPA), an amount similar to that previously documented in healthy children. Only three of the 19 subjects averaged less MVPA than the recommended amount (at least 60 min/day). MVPA levels were significantly higher on weekdays than weekend days (P= 0.006). Overall, boys engaged in significantly more MVPA than girls (P= 0.029). MVPA time was negatively correlated with age (r =-0.80) and age at diagnosis (r =-0.87). No trend between MVPA and time off treatment or body mass index was identified. CONCLUSIONS: Survivors of childhood ALL appear to be engaging in similar amounts of MVPA as those of the healthy children and are meeting recommended levels of physical activity.
AIM: To objectively measure levels of physical activity in children, following treatment for acute lymphoblastic leukaemia (ALL). METHODS: Nineteen children who had completed treatment for ALL 6 months-5 years prior to study enrollment wore an accelerometer for 2 weekdays and 2 weekend days. RESULTS: The children spent an average of 141 +/- 74 min/day engaged in moderate to vigorous physical activity (MVPA), an amount similar to that previously documented in healthy children. Only three of the 19 subjects averaged less MVPA than the recommended amount (at least 60 min/day). MVPA levels were significantly higher on weekdays than weekend days (P= 0.006). Overall, boys engaged in significantly more MVPA than girls (P= 0.029). MVPA time was negatively correlated with age (r =-0.80) and age at diagnosis (r =-0.87). No trend between MVPA and time off treatment or body mass index was identified. CONCLUSIONS: Survivors of childhood ALL appear to be engaging in similar amounts of MVPA as those of the healthy children and are meeting recommended levels of physical activity.
Authors: Margaux B Gilliam; Avi Madan-Swain; Kimberly Whelan; Diane C Tucker; Wendy Demark-Wahnefried; David C Schwebel Journal: J Pediatr Psychol Date: 2011-10-17
Authors: Jennifer A Hansen; Heather H Stancel; Lisa M Klesges; Vida L Tyc; Pamela S Hinds; Shengjie Wu; Melissa M Hudson; Lisa S Kahalley Journal: J Pediatr Oncol Nurs Date: 2014-01-22 Impact factor: 1.636
Authors: Megan C Hoffman; Daniel A Mulrooney; Julia Steinberger; Jill Lee; K Scott Baker; Kirsten K Ness Journal: J Clin Oncol Date: 2013-06-24 Impact factor: 44.544
Authors: Rona J Mogil; Sue C Kaste; Robert J Ferry; Melissa M Hudson; Daniel A Mulrooney; Carrie R Howell; Robyn E Partin; Deo K Srivastava; Leslie L Robison; Kirsten K Ness Journal: JAMA Oncol Date: 2016-07-01 Impact factor: 31.777
Authors: Sogol Mostoufi-Moab; Jill Brodsky; Elizabeth J Isaacoff; Anne Tsampalieros; Jill P Ginsberg; Babette Zemel; Justine Shults; Mary B Leonard Journal: J Clin Endocrinol Metab Date: 2012-08-03 Impact factor: 5.958
Authors: Moniek Akkerman; Leonora J Mouton; Laurien M Disseldorp; Anuschka S Niemeijer; Marco van Brussel; Lucas H V van der Woude; Marianne K Nieuwenhuis Journal: BMC Sports Sci Med Rehabil Date: 2018-02-09